corrigendum to:Prostate specific membrane antigen (PSMA): A novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells (Prostatem, (2013), 73, 8, (835–41), 10.1002/pros.22627);Prostate specific membrane antigen (PSMA): A novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells

Prostate

Volumn 73, Issue 8, 2013, Pages 835-841

  Zhang, Yiming ^a   Guo, Zhenghui ^a   Du, Tao ^a   Chen, Jieqing ^a   Wang, Wei ^b   Xu, Kewei ^a   Lin, Tianxin ^a   Huang, Hai ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

p38; prostate cancer; prostate specific membrane antigen; PSMA

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; SYNAPTOPHYSIN;

ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE SILENCING; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

EID: 84876901422     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.24093     Document Type: Erratum

References (23)

1. Israeli RS, Powell CT, Fair WR, Heston WD,. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993; 53 (2): 227-230.
2. O'Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder HR, Fair WR, Heston WD,. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta 1998; 1443 (1-2): 113-127.
3. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C,. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997; 3 (1): 81-85.
4. Wright GJ, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, Moriarty R,. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 1996; 48 (2): 326-334.
5. Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WD,. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 1996; 2 (9): 1445-1451.
6. Ghosh A, Heston WD,. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 2004; 91 (3): 528-539.
7. Han J, Lee JD, Bibbs L, Ulevitch RJ,. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265 (5173): 808-811.
8. Cuadrado A, Nebreda AR,. Mechanisms and functions of p38 MAPK signalling. Biochem J 2010; 429 (3): 403-417.
9. Enslen H, Raingeaud J, Davis RJ,. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 1998; 273 (3): 1741-1748.
10. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, Kyuuma M, Takeshita T, Flavell RA, Davis RJ,. Mechanism of p38 MAP kinase activation in vivo. Genes Dev 2003; 17 (16): 1969-1978.
11. Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GR, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG,. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol Chem 1999; 274 (11): 7341-7350.
12. Ricote M, Garcia-Tunon I, Bethencourt F, Fraile B, Onsurbe P, Paniagua R, Royuela M,. The p38 transduction pathway in prostatic neoplasia. J Pathol 2006; 208 (3): 401-407.
13. Recio JA, Merlino G,. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 2002; 21 (7): 1000-1008.
14. Comes F, Matrone A, Lastella P, Nico B, Susca FC, Bagnulo R, Ingravallo G, Modica S, Lo SG, Moschetta A, Guanti G, Simone C,. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ 2007; 14 (4): 693-702.
15. Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL, Sabio G, Davis RJ, Matthews DE, Doble B, Rincon M,. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 2008; 320 (5876): 667-670.
16. Thornton TM, Rincon M,. Non-classical p38 map kinase functions: Cell cycle checkpoints and survival. Int J Biol Sci 2009; 5 (1): 44-51.
17. Wagner EF, Nebreda AR,. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9 (8): 537-549.
18. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY,. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 2007; 67 (9): 4320-4327.
19. Junttila MR, Ala-Aho R, Jokilehto T, Peltonen J, Kallajoki M, Grenman R, Jaakkola P, Westermarck J, Kahari VM,. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells. Oncogene 2007; 26 (36): 5267-5279.
20. Kim MS, Lee EJ, Kim HR, Moon A,. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003; 63 (17): 5454-5461.
21. Dreissigacker U, Mueller MS, Unger M, Siegert P, Genze F, Gierschik P, Giehl K,. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. Cell Signal 2006; 18 (8): 1156-1168.
22. McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM,. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 2005; 280 (22): 20995-21003.
23. Guo Z, Huang H, Zeng L, Du T, Xu K, Lin T, Jiang C, Dong W, Cao Y, Chen J, Zhong W, Huang J,. Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells. Med Oncol 2011; 28 (3): 878-887.